SecBot SecBot
SECBOTREPLAY Home › Report › UTHR

UTHR · Four corporate insiders at United Therapeutics, including the CEO, CFO,…

UNITED THERAPEUTICS Corp · CLUSTER filed Apr 16, 2026 at 16:31 ET

At the news

NEUTRALIMPACT 3/10

CLUSTER filed Apr 16, 2026 at 16:31 ET

Four corporate insiders at United Therapeutics, including the CEO, CFO, and General Counsel, sold shares in open-market transactions over a 5-day period, realizing $1.34 million in total proceeds. These sales were part of broader option exercise and tax-related transactions, with multiple executives exercising in-the-money options and selling a portion of the resulting shares.

  • CEO Martine Rothblatt sold $702,522 worth of shares over two days (248 shares on 4/17, 977 on 4/20) at prices between $572.41 and $575.38
  • CFO James Edgemon sold $802,084 in shares (520 on 4/16, 880 on 4/20) following the exercise of 20,000 options
  • EVP Paul Mahon sold $114,807 after exercising 8,300 options
  • Director Christopher Patusky sold $578,880 following the exercise of 1,000 options

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access